In 2025, WHO published its first clinical guideline on the use of GLP-1 therapies for the treatment of obesity in adults. Its position is clear: obesity is a chronic, complex, relapsing disease requiring lifelong care, and GLP-1 medication is one component of a multimodal chronic care model. The guideline explicitly recommends that people living with obesity receive behavioural and lifestyle counselling as a minimum standard of care, and that intensive behavioural therapy (IBT) should be provided as a co-intervention alongside GLP-1 medications within a comprehensive clinical algorithm.

The WHO defines IBT as structured, psychologically informed support including goal-setting, counselling, and periodic assessment of goal attainment. Delivering it properly requires trained practitioners and a coherent clinical framework. The 2025 WHO guideline identifies comprehensive training of health workers as a core implementation requirement, placing it alongside governance, monitoring, and referral systems as a structural necessity.

NICE guidelines for weight management similarly emphasise behavioural intervention alongside dietary and physical activity support, with psychological factors recognised as central to long-term outcomes. For patients meeting criteria for Binge Eating Disorder, NICE recommends psychological therapy, typically CBT, as the primary treatment.

The evidence base on what works is substantial. A 2025 systematic review and meta-analysis published in the Journal of Human Nutrition and Dietetics, drawing on 47 studies and nearly 7,000 participants, identified the specific behaviour change techniques most effective for emotional eating (Power et al., 2025).

The five associated with the greatest impact on both emotional eating and weight were: incompatible beliefs, goal setting (outcome), reviewing outcome goals, feedback on behaviour, and pros and cons. These are associated with reductions in emotional eating scores of between 0.99 and 1.46 standardised mean difference, which is considered a large clinical effect, and average weight reductions of between 5.4kg and 8.4kg as a natural byproduct of addressing the psychological drivers rather than targeting weight directly.

All five techniques centre on identity, values, and self-regulation. They require skilled, structured facilitation by practitioners with genuine competence in the psychology of eating behaviour.

The Eating Freely programme was built around these evidence-identified techniques, integrating CBT, Acceptance and Commitment Therapy, mindfulness, self-compassion, nutritional rehabilitation, and neuroscience-informed psychoeducation within a trauma-informed, weight-inclusive framework, before WHO guidelines for weight management services and GLP-1 pathways were ever published.

Most services currently do not screen at all, and the clinical consequences are significant.

Research shows that up to 58% of adults referred to weight management services report struggling with emotional eating (Wong et al., 2020).

The More Than Weight Report (2025) published by West Yorkshire ICB found that 66% of service users report frequent emotional eating, 78% have a co-existing mental health or neurodevelopmental condition, and 0% are routinely screened for eating disorders before treatment begins.

The Power et al. systematic review concluded explicitly that weight management services should screen patients for emotional eating in order to tailor interventions to individual needs.
Screening serves two clinical functions. It identifies patients at risk of harm from inadequately supported interventions, and it enables personalisation of care, which the evidence shows materially improves outcomes.

Two validated tools are particularly relevant for this population.
The Three Factor Eating Questionnaire (TFEQ-R21) measures emotional eating, uncontrolled eating, and cognitive restraint. It is well-validated, widely used in research and clinical settings, and provides a clear baseline against which change can be tracked over time. It is the primary outcome measure used in the Eating Freely feasibility pilot and the tool we recommend for outcome monitoring in weight management services.

The BEDS-7 (Binge Eating Disorder Screener-7) is a brief, freely available self-report measure that can be administered as part of an initial assessment without specialist training. It provides a clear indication of which patients are likely to meet diagnostic criteria for Binge Eating Disorder and therefore require a more specialist pathway or referral.

The Eating Freely team training equips practitioners with the clinical knowledge to interpret screening results, respond within their scope of practice, and refer appropriately for patients requiring specialist input.

Yes, and the gap between what guidelines recommend and what most services deliver is now well documented.

The 2025 WHO guideline makes two directly relevant statements. A good practice statement confirms that people living with obesity should receive context-appropriate behavioural counselling as a minimum standard of care, and that for individuals prescribed GLP-1 medications, this should be a first step toward intensive behavioural therapy. A conditional recommendation confirms that intensive behavioural therapy may be provided as a co-intervention within a comprehensive multimodal clinical algorithm for patients on GLP-1 medications.

NICE guidance on weight management similarly identifies behavioural and psychological support as integral to effective care, with specific recommendations for patients presenting with disordered eating patterns.

The evidence underpinning these recommendations is robust. The Power et al. meta-analysis found that psychological interventions targeting emotional eating produced a standardised mean difference in emotional eating scores of -0.99 across 42 studies and nearly 7,000 participants, a large clinical effect. Average weight loss of 4.09kg was observed as a byproduct across 32 studies, without dietary restriction as the primary focus. The review also found that the specific nature of the behaviour change techniques used matters more than the quantity, pointing toward the need for specifically designed, evidence-informed programmes.

The Eating Freely feasibility pilot found a 27.7% reduction in emotional eating scores from baseline to follow-up using the Three Factor Eating Questionnaire, with improvements continuing beyond the end of the programme. Average weight loss was 4.2kg, achieved without any weight loss focus in the programme. Programme attendance averaged 13.75 out of 16 sessions.

The Eating Freely framework gives services the training, tools, and patient programme needed to meet both NICE and WHO guidance, with independent validation and CE/CPD approval already in place.

GLP-1 medications are effective at reducing appetite and supporting significant short to medium term weight loss. The clinical trial evidence summarised in the 2025 WHO guideline shows average weight reductions of between 5% and 16% during treatment.

The medication does not address the psychological relationship a person has with food, their body, or themselves, and the clinical consequences of that gap are becoming increasingly visible in practice.

The WHO guideline acknowledges limited data around discontinuation of GLP-1 medications, noting that available evidence is insufficient to inform clear clinical guidance. What services are beginning to observe aligns with what clinicians working in disordered eating have understood for years: patients who have not addressed the psychological drivers of their eating behaviour are at significant risk of weight regain when appetite suppression is reduced, sometimes returning to patterns more entrenched than those they presented with at the start.

The specific psychological challenges that require structured support in GLP-1 care include identity shift and adjustment to a changing body; persistent food noise that medication may reduce but rarely eliminates; grief when medication stops producing expected results; body image adjustment; and the risk of disordered eating patterns worsening when pharmacological effect is removed.

For patients with pre-existing emotional eating or binge eating disorder, these risks are compounded. The Power et al. systematic review found that emotional eating is associated with emotional regulation difficulties, trauma histories, and addictive behaviours, with shared psychological mechanisms between disordered eating and substance misuse. These are not characteristics addressable through dietary advice or activity coaching.

The WHO guideline states that effective obesity care must address the full spectrum of health, social, and psychological impacts of the condition across the life course, embedded in multimodal clinical algorithms that integrate behaviour change support, pharmacotherapy, long-term follow-up, and supportive environments.

The Eating Freely programme gives patients the psychological tools to understand their relationship with food, build lasting coping strategies, and sustain behavioural change beyond the period of medication use.

The WHO guideline on GLP-1 therapies identifies comprehensive training of health workers as a core implementation requirement for chronic obesity care, placing it alongside governance, monitoring, and referral systems as a structural necessity.

The Power et al. systematic review found that effective emotional eating interventions use specific behaviour change techniques centred on identity, self-regulation, and psychological flexibility. Delivering these safely and effectively requires working clinical knowledge of the psychological drivers of eating behaviour, a trauma-informed approach to patient interaction, specific tools usable within a practitioner's existing scope of practice, and ongoing support during implementation.

The Eating Freely practitioner training provides this. It consists of a one-day intensive foundation session, followed by six weeks of self-paced learning via our online portal and practitioner community, with ongoing supervision and clinical troubleshooting support throughout implementation. The training is CE/CPD approved across the UK, USA, Australia, and South Africa.

Training is accompanied by the full Eating Freely patient programme: a structured, digitally-delivered programme giving practitioners a validated clinical framework and patient-facing resources from day one. For organisations wanting to embed this at scale, the programme can be licensed and white-labelled, delivered under the service's own brand and integrated into existing care pathways.

The Eating Freely practitioner network is available as a referral resource for complex cases requiring specialist input.

Most organisations can be operational within 12 weeks of signing a partnership agreement. This includes a full onboarding programme, practitioner training, clinical resources, and ongoing supervision support as the patient programme is rolled out. We work around your team's schedule.

Our training is designed specifically for health professionals without a therapy background. For complex presentations including Binge Eating Disorder, our full specialist training is suitable for an experienced practitioner with some grounding in psychology or therapy. These complex patients can also be referred to trained specialists within our network.

Yes. Our Strategic Partnership tier includes white-label options, allowing you to deliver the programme under your own service brand. We can also co-develop bespoke care pathways that integrate with your existing clinical framework. Contact us to discuss your specific requirements.

We offer three partnership tiers at different investment levels to suit services of varying size and need. Pricing is provided following a zoom call, where we can assess your specific requirements and recommend the most appropriate tier. Book a call to receive a tailored proposal.

Yes. The programme is designed to align with NICE guidelines and WHO recommendations, making it suitable for NHS Tier 2 and Tier 3 weight management services, primary care networks, and integrated care boards. Applications are now open for our NHS multi-site pilot and service evaluation, learn more and submit an Expression of Interest here: https://eatingfreelyinstitute.com/nhs/